Neoadjuvant Chemoimmunotherapy in Recurrent Glioblastoma
Condition: Glioblastoma Intervention: Drug: Pembrolizumab and Temozolomide Sponsor: University of Louisville Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials